Simcere Pharmaceutical Group (NYSE:SCR) will release the third quarter earnings for 2009 on Monday, November 16. The company will host a conference call at 8:00 am ET that morning to discuss the financial results. Joining the call will be Simcere Chief Executive Officer Jinsheng Ren, and Chief Financial Officer Frank Zhigang Zhao. Interested parties may join the call by dialing one of the following numbers:
United States toll-free: +1.800.706.7741International: +1.617.614.3471North China toll-free: 10.800.152.1490South China toll-free: 10.800.130.0399China toll free / Netcom: 10.800.852.1490Hong Kong: +852.3002.1672
A telephone replay of the call will be available at 1.888.286.8010 (US toll-free), or 1.617.801.6888 (International), pass code 77133325. The replay will also be archived on the Investor Relations section of the company’s website, www.simcere.com, for thirty days following the end of the call.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Simcere Pharmaceutical Group is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. The Company has introduced a generic anti-stroke medication under the brand name Bicun, a 5-FU sustained release implant under the brand name Sinofuan and an anti-cancer medication under the brand name Endu. It manufactures and sells 45 principal pharmaceutical products and is the distributor of three additional pharmaceuticals that are manufactured by independent third parties but marketed under its brand names. On May 5, 2008, it acquired 70% interest in Wuhu Zhong Ren Pharmaceutical Co., Ltd. (Wuhu Simcere Zhong Ren). On January 6, 2009, Simcere Pharmaceutical Group acquired the remaining 10% of interest of Shandong Simcere Medgenn Bio-Pharmaceutical Co., Ltd. (Shandong Simcere).
Sign up for the free Best Damn Penny Socks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
